Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: The leaves of the shrub Vernonia amygdalina Del (Compositae) are widely used in Africa to treat malaria. It is widely available, accessible, and affordable in many remote areas that do not have ready access to modern medicines. INTERVENTION: This study examined the efficacy and safety of an infusion of fresh V. amygdalina leaves for the treatment of uncomplicated malaria in patients aged 12 years and over. OUTCOME MEASURES: The primary outcome measure was an adequate clinical response. The secondary outcome measure was incidence of adverse events, assumed to be side-effects of the medicine. RESULTS: The remedy was associated with an adequate clinical response (ACR) at day 14 in 67% of cases. However, complete parasite clearance occurred in only 32% of those with ACR, and of these, recrudescence occurred in 71%. There was no evidence of significant side-effects or toxicity from the medication. There was a trend toward a reduction in hemoglobin between day 0 and day 28, although this did not reach statistical significance. CONCLUSIONS: Further studies are needed to determine whether the efficacy can be improved by increasing the dose, changing the preparation, or adding other antimalarial plants.

Original publication

DOI

10.1089/acm.2009.0098

Type

Journal article

Journal

J Altern Complement Med

Publication Date

11/2009

Volume

15

Pages

1231 - 1237

Keywords

Adolescent, Adult, Antimalarials, Asteraceae, Female, Hemoglobins, Humans, Malaria, Falciparum, Male, Middle Aged, Phytotherapy, Plant Extracts, Plant Leaves, Plasmodium falciparum, Prospective Studies, Uganda, Young Adult